Astellas Pharma Inc., based in Tokyo, Japan, is a company dedicated to improving the health of people around the world.
Astellas Established Markets-Commercial (EST-C) is a regional business with headquarters in the UK, supporting teams across Europe, Australia and Canada.
Astellas’ raison d’être is to “contribute toward improving the health of people around the world through the provision of innovative and reliable pharmaceutical products.”
Based on this, we aim to stand on the forefront of healthcare change, turning innovative science into value for patients.
Currently, we are proud to have been involved in transplantation for more than 20 years and continue to invest in this area, supporting multiple transplant organizations around the world. Our portfolio provides treatment options for people receiving kidney, liver and heart transplants.
We have introduced treatments that have helped address the unmet needs of patients and are continuing to expand our urology portfolio through developing next-generation therapies.
We are committed to the fight against cancer. Over the last decade, we have built a leadership position and a substantial oncology pipeline. We are focused on discovering new cancer treatments and novel pathways, particularly in hard-to-treat cancers where few therapies exist.
Around 17% of our global annual sales are reinvested into cutting-edge science, and it is this commitment that allows us to develop new treatments that help address the unmet medical needs of patients around the world.
A Focus Area Approach for our research and development strategy has been established. Specifically, our Focus Area Strategy is defined as combinations of three components: (1) biologics with high disease relevance, (2) versatile modalities/technologies, and (3) diseases with high unmet medical needs that are expected to be tackled by the first two components. We view this strategy as a way to build a sustainable, expandable drug discovery approach to develop new platforms, leverage expertise and create innovative products.
With a great culture of teamwork that has grown from our Japanese roots, with over 100 ongoing collaborative research projects globally, through our partnerships, networks and proactive engagement with medical experts and academia, we work side-by-side with those who share our vision and complement our expertise, to help us stay at the forefront of pioneering medical discovery.
Our employees are passionate about their work and are the driving force behind our dynamic organization. We are all continually learning and challenging ourselves to make a difference to the lives of patients.
ONC_2021_0017_BE/Last Update February 2021
Astellas and the flying star logo are registered trademarks of Astellas pharma INC